Reviewed,
UniProtKB/Swiss-Prot P01106 (MYC_HUMAN)
Last modified
February 9, 2010.
Version 142.
History...
Clusters with 100%,
90%,
50% identity |
Documents (6) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Myc proto-oncogene protein Alternative name(s): Proto-oncogene c-Myc Transcription factor p64 Class E basic helix-loop-helix protein 39 Short name=bHLHe39 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Complete proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 439 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Participates in the regulation of gene transcription. Binds DNA in a non-specific manner, yet also specifically recognizes the core sequence 5'-CAC[GA]TG-3'. Seems to activate the transcription of growth-related genes. |
| Subunit structure | Efficient DNA binding requires dimerization with another bHLH protein. Binds DNA as a heterodimer with MAX. Interacts with TAF1C and SPAG9. Interacts with PARP10. Interacts with KDM5A and KDM5B. Ref.22 Ref.23 Ref.25 |
| Subcellular location | |
| Post-translational modification | Phosphorylated by PRKDC. Ref.17 Ref.18 Ref.20 Ref.24 Ref.26 Ref.27 |
| Involvement in disease | Overexpression of MYC is implicated in the etiology of a variety of hematopoietic tumors. A chromosomal aberration involving MYC may be a cause of a form of B-cell chronic lymphocytic leukemia. Translocation t(8;12)(q24;q22) with BTG1. |
| Sequence similarities | Contains 1 basic helix-loop-helix (bHLH) domain. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| P03070 | 1 | EBI-447544,EBI-617698 | From a different organism. | |
| CHD4 | Q14839 | 1 | EBI-447544,EBI-372916 | |
| EFTUD2 | Q15029 | 2 | EBI-447544,EBI-357897 | |
| EP300 | Q09472 | 1 | EBI-447544,EBI-447295 | |
| FBXW7 | Q969H0 | 1 | EBI-447544,EBI-359574 | |
| FBXW8 | Q8N3Y1 | 1 | EBI-447544,EBI-914770 | |
| KIAA1524 | Q8TCG1 | 2 | EBI-447544,EBI-1379376 | |
| KIAA1967 | Q8N163 | 2 | EBI-447544,EBI-355410 | |
| MAX | P61244 | 8 | EBI-447544,EBI-878388 | |
| Max | P52164 | 2 | EBI-447544,EBI-1184963 | From a different organism. |
| MCM7 | P33993 | 2 | EBI-447544,EBI-355924 | |
| PIAS2 | O75928 | 2 | EBI-447544,EBI-348555 | |
| SKP2 | Q13309 | 2 | EBI-447544,EBI-456291 | |
| SNIP1 | Q8TAD8 | 5 | EBI-447544,EBI-749336 | |
| SP1 | P08047 | 2 | EBI-447544,EBI-298336 | |
| TRRAP | Q9Y4A5 | 2 | EBI-447544,EBI-399128 | |
| vIRF-3 | Q9DUN1 | 1 | EBI-447544,EBI-1647907 | From a different organism. |
| ZBTB17 | Q13105 | 1 | EBI-447544,EBI-372156 |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | |||||||||
| Isoform 1 (identifier: P01106-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | |||||||||
| Isoform 2 (identifier: P01106-2) The sequence of this isoform differs from the canonical sequence as follows: 1-1: M → MDFFRVVENQQPPATM | |||||||||
| Note: Initiates from CTG codon. | |||||||||
Sequence annotation (Features) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
| Sequence conflict | 2 | 1 | D → N in BAA01374. Ref.7 | ||||||
| Sequence conflict | 6 | 1 | V → E in BAA01374. Ref.7 | ||||||
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||
Molecule processing | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 439 | 439 | Myc proto-oncogene protein | PRO_0000127293 | |||||||||||
Regions | |||||||||||||||
| Domain | 368 – 407 | 40 | Helix-loop-helix motif | ||||||||||||
| Domain | 413 – 434 | 22 | Leucine-zipper | ||||||||||||
| DNA binding | 354 – 367 | 14 | Basic motif | ||||||||||||
| Compositional bias | 33 – 37 | 5 | Poly-Gln | ||||||||||||
| Compositional bias | 88 – 91 | 4 | Poly-Gly | ||||||||||||
Amino acid modifications | |||||||||||||||
| Modified residue | 6 | 1 | Phosphoserine Ref.27 | ||||||||||||
| Modified residue | 8 | 1 | Phosphothreonine; by RAF; in vitro Ref.20 | ||||||||||||
| Modified residue | 58 | 1 | Phosphothreonine; alternate Ref.18 Ref.24 Ref.26 | ||||||||||||
| Modified residue | 62 | 1 | Phosphoserine Ref.18 Ref.24 Ref.26 | ||||||||||||
| Modified residue | 71 | 1 | Phosphoserine Ref.26 | ||||||||||||
| Modified residue | 143 | 1 | N6-acetyllysine; by PCAF Ref.21 | ||||||||||||
| Modified residue | 148 | 1 | N6-acetyllysine Ref.28 | ||||||||||||
| Modified residue | 157 | 1 | N6-acetyllysine; by PCAF Ref.21 | ||||||||||||
| Modified residue | 275 | 1 | N6-acetyllysine; by PCAF Ref.21 | ||||||||||||
| Modified residue | 317 | 1 | N6-acetyllysine; by PCAF Ref.21 | ||||||||||||
| Modified residue | 323 | 1 | N6-acetyllysine; by PCAF Ref.21 | ||||||||||||
| Modified residue | 344 | 1 | Phosphoserine Ref.27 | ||||||||||||
| Modified residue | 348 | 1 | Phosphoserine Ref.27 | ||||||||||||
| Modified residue | 371 | 1 | N6-acetyllysine; by PCAF Ref.21 | ||||||||||||
| Glycosylation | 58 | 1 | O-linked (GlcNAc); alternate Ref.19 | CAR_000033 | |||||||||||
Natural variations | |||||||||||||||
| Alternative sequence | 1 | 1 | M → MDFFRVVENQQPPATM in isoform 2. | VSP_037813 | |||||||||||
| Natural variant | 11 | 1 | N → S: dbSNP rs4645959. Ref.11 | VAR_016327 | |||||||||||
| Natural variant | 160 | 1 | G → C: dbSNP rs4645960. Ref.11 | VAR_016328 | |||||||||||
| Natural variant | 170 | 1 | V → I: dbSNP rs4645961. Ref.11 | VAR_016329 | |||||||||||
| Natural variant | 322 | 1 | A → V: dbSNP rs4645968. Ref.11 | VAR_016330 | |||||||||||
Experimental info | |||||||||||||||
| Sequence conflict | 6 – 7 | 2 | SF → TI Ref.5 | ||||||||||||
| Sequence conflict | 10 | 1 | R → K Ref.5 | ||||||||||||
| Sequence conflict | 39 | 1 | E → D Ref.5 | ||||||||||||
| Sequence conflict | 56 | 1 | L → LL Ref.5 | ||||||||||||
| Sequence conflict | 62 | 1 | S → P in CAA25288. Ref.7 | ||||||||||||
| Sequence conflict | 88 | 1 | G → D Ref.5 | ||||||||||||
| Sequence conflict | 92 | 1 | S → N Ref.5 | ||||||||||||
| Sequence conflict | 114 | 1 | S → N Ref.5 | ||||||||||||
| Sequence conflict | 120 | 1 | D → G Ref.5 | ||||||||||||
| Sequence conflict | 171 | 1 | C → S Ref.5 | ||||||||||||
| Sequence conflict | 203 | 1 | S → R Ref.5 | ||||||||||||
| Sequence conflict | 230 | 1 | S → A Ref.5 | ||||||||||||
| Sequence conflict | 240 | 1 | L → F Ref.5 | ||||||||||||
| Sequence conflict | 245 | 1 | P → S Ref.5 | ||||||||||||
Secondary structure | |||||||||||||||
Helix Strand Turn | |||||||||||||||
| Helix | 353 – 378 | 26 | |||||||||||||
| Helix | 382 – 384 | 3 | |||||||||||||
| Helix | 392 – 434 | 43 | |||||||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "The human c-myc oncogene: structural consequences of translocation into the IgH locus in Burkitt lymphoma." Battey J., Moulding C., Taub R., Murphy W., Stewart T., Potter H., Lenoir G., Leder P. Cell 34:779-787(1983) [PubMed: 6414718] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], ALTERNATIVE SPLICING (ISOFORM 1). |
| [2] | "Sequence of the murine and human cellular myc oncogenes and two modes of myc transcription resulting from chromosome translocation in B lymphoid tumours." Bernard O., Cory S., Gerondakis S., Webb E., Adams J.M. EMBO J. 2:2375-2383(1983) [PubMed: 6321164] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], ALTERNATIVE SPLICING (ISOFORM 1). |
| [3] | "Identification and nucleotide sequence of a human locus homologous to the v-myc oncogene of avian myelocytomatosis virus MC29." Colby W.W., Chen E.Y., Smith D.H., Levinson A.D. Nature 301:722-725(1983) [PubMed: 6298632] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], ALTERNATIVE SPLICING (ISOFORM 1). |
| [4] | "Nucleotide sequence of cloned cDNA of human c-myc oncogene." Watt R., Stanton L.W., Marcu K.B., Gallo R.C., Croce C.M., Rovera G. Nature 303:725-728(1983) [PubMed: 6304538] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). |
| [5] | "Altered nucleotide sequences of a translocated c-myc gene in Burkitt lymphoma." Rabbitts T.H., Hamlyn P.H., Baer R. Nature 306:760-765(1983) [PubMed: 6419122] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). |
| [6] | "Nucleotide sequence analysis of human c-myc locus, chicken homologue, and myelocytomatosis virus MC29 transforming gene reveals a highly conserved gene product." Watson D.K., Psallidopoulos M.C., Samuel K.P., Dalla-Favera R., Papas T.S. Proc. Natl. Acad. Sci. U.S.A. 80:3642-3645(1983) [PubMed: 6304729] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], ALTERNATIVE SPLICING (ISOFORM 1). |
| [7] | "Effect of somatic mutation within translocated c-myc genes in Burkitt's lymphoma." Rabbitts T.H., Forster A., Hamlyn P., Baer R. Nature 309:592-597(1984) [PubMed: 6547209] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-252. |
| [8] | "Nucleotide sequence of the human c-myc locus: provocative open reading frame within the first exon." Gazin C., Dupont S., de Dinechin D., Hampe A., Masson J.-M., Martin P., Stehelin D., Galibert F. EMBO J. 3:383-387(1984) [PubMed: 6714223] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], ALTERNATIVE SPLICING (ISOFORM 1). |
| [9] | "Allele-specific activation of the c-myc gene in an atypical Burkitt's lymphoma carrying the t(2;8) chromosomal translocation 250 kb downstream from c-myc." Tachibana K., Takayama N., Matsuo K., Kato S., Yamamoto K., Ohyama K., Umezawa A., Takano T. Gene 124:231-237(1993) [PubMed: 8444346] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], ALTERNATIVE SPLICING (ISOFORMS 1 AND 2). |
| [10] | "Cloning of human full-length CDSs in BD Creator(TM) system donor vector." Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., Phelan M., Farmer A. Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). |
| [11] | NIEHS SNPs program Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS SER-11; CYS-160; ILE-170 AND VAL-322. |
| [12] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Uterus. |
| [13] | "DNA sequence and analysis of human chromosome 8." Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S., Asakawa T. Lander E.S.Nature 439:331-335(2006) [PubMed: 16421571] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [14] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [15] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Tissue: Cervix, Placenta and Testis. |
| [16] | "Novel promoter upstream of the human c-myc gene and regulation of c-myc expression in B-cell lymphomas." Bentley D.L., Groudine M. Mol. Cell. Biol. 6:3481-3489(1986) [PubMed: 3540591] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1-170 (ISOFORM 1). Tissue: Promyelocytic leukemia. |
| [17] | "DNA-activated protein kinase in Raji Burkitt's lymphoma cells. Phosphorylation of c-Myc oncoprotein." Iijima S., Teraoka H., Date T., Tsukada K. Eur. J. Biochem. 206:595-603(1992) [PubMed: 1597196] [Abstract] Cited for: PHOSPHORYLATION. |
| [18] | "Transactivation of gene expression by Myc is inhibited by mutation at the phosphorylation sites Thr-58 and Ser-62." Gupta S., Seth A., Davis R.J. Proc. Natl. Acad. Sci. U.S.A. 90:3216-3220(1993) [PubMed: 8386367] [Abstract] Cited for: PHOSPHORYLATION AT THR-58 AND SER-62. |
| [19] | "c-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas." Chou T.-Y., Hart G.W., Dang C.V. J. Biol. Chem. 270:18961-18965(1995) [PubMed: 7642555] [Abstract] Cited for: GLYCOSYLATION AT THR-58. |
| [20] | "c-Raf kinase binds to N-terminal domain of c-Myc." Alexandrov I., Shlyakhova L., Vartanian A., Zajac-Kaye M., Alexandrova N. FEBS Lett. 414:465-470(1997) [PubMed: 9315742] [Abstract] Cited for: PHOSPHORYLATION AT THR-8. |
| [21] | "Six lysine residues on c-Myc are direct substrates for acetylation by p300." Zhang K., Faiola F., Martinez E. Biochem. Biophys. Res. Commun. 336:274-280(2005) [PubMed: 16126174] [Abstract] Cited for: ACETYLATION AT LYS-143; LYS-157; LYS-275; LYS-317; LYS-323 AND LYS-371, MASS SPECTROMETRY. |
| [22] | "c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I." Grandori C., Gomez-Roman N., Felton-Edkins Z.A., Ngouenet C., Galloway D.A., Eisenman R.N., White R.J. Nat. Cell Biol. 7:311-318(2005) [PubMed: 15723054] [Abstract] Cited for: INTERACTION WITH TAF1C. |
| [23] | "PARP-10, a novel Myc-interacting protein with poly(ADP-ribose) polymerase activity, inhibits transformation." Yu M., Schreek S., Cerni C., Schamberger C., Lesniewicz K., Poreba E., Vervoorts J., Walsemann G., Groetzinger J., Kremmer E., Mehraein Y., Mertsching J., Kraft R., Austen M., Luescher-Firzlaff J., Luescher B. Oncogene 24:1982-1993(2005) [PubMed: 15674325] [Abstract] Cited for: INTERACTION WITH PARP10. |
| [24] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-58 AND SER-62, MASS SPECTROMETRY. Tissue: Epithelium. |
| [25] | "The Trithorax group protein Lid is a trimethyl histone H3K4 demethylase required for dMyc-induced cell growth." Secombe J., Li L., Carlos L., Eisenman R.N. Genes Dev. 21:537-551(2007) [PubMed: 17311883] [Abstract] Cited for: INTERACTION WITH KDM5A AND KDM5B. |
| [26] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-58; SER-62 AND SER-71, MASS SPECTROMETRY. |
| [27] | "Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach." Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S. Anal. Chem. 81:4493-4501(2009) [PubMed: 19413330] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6; SER-344 AND SER-348, MASS SPECTROMETRY. |
| [28] | "Lysine acetylation targets protein complexes and co-regulates major cellular functions." Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T., Olsen J.V., Mann M. Science 325:834-840(2009) [PubMed: 19608861] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-148, MASS SPECTROMETRY. |
| [29] | "Insights into the mechanism of heterodimerization from the 1H-NMR solution structure of the c-Myc-Max heterodimeric leucine zipper." Lavigne P., Crump M.P., Gagne S.M., Hodges R.S., Kay C.M., Sykes B.D. J. Mol. Biol. 281:165-181(1998) [PubMed: 9680483] [Abstract] Cited for: STRUCTURE BY NMR OF 402-434 IN COMPLEX WITH MAX. |
| + | Additional computationally mapped references. |
Web resources
Cross-references
Sequence databases | |||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | L00058, L00057 Genomic DNA. Translation: AAA59882.1. K00535, K00534 Genomic DNA. Translation: AAA59880.1. K00535, K00534 Genomic DNA. Translation: ABW69847.1. X00196, X00198 Genomic DNA. Translation: CAA25015.2. X00364 Genomic DNA. Translation: CAA25106.1. V00568 mRNA. Translation: CAA23831.1. K01906, K01905 Genomic DNA. Translation: AAA59881.1. K02276 mRNA. Translation: AAA36340.1. X00676 Genomic DNA. Translation: CAA25288.1. D10493 Genomic DNA. Translation: BAA01374.2. D10493 Genomic DNA. Translation: BAA01375.1. BT019768 mRNA. Translation: AAV38573.1. AY214166 Genomic DNA. Translation: AAO21131.1. AK312883 mRNA. Translation: BAG35731.1. AC103819 Genomic DNA. No translation available. CH471060 Genomic DNA. Translation: EAW92098.1. BC000141 mRNA. Translation: AAH00141.2. BC000917 mRNA. Translation: AAH00917.2. BC058901 mRNA. Translation: AAH58901.2. M13929 mRNA. Translation: AAA88092.1. | ||||||||||||||||||||||||||||||||||||
| IPI | IPI00033016. IPI00935431. | ||||||||||||||||||||||||||||||||||||
| PIR | TVHUM. A01349. TVHUT. A01350. | ||||||||||||||||||||||||||||||||||||
| RefSeq | NP_002458.2. | ||||||||||||||||||||||||||||||||||||
| UniGene | Hs.202453 | ||||||||||||||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||||||||||||||
| DisProt | DP00260. | ||||||||||||||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||||||||||||||
| DIP | DIP-28143N. | ||||||||||||||||||||||||||||||||||||
| IntAct | P01106. 237 interactions. | ||||||||||||||||||||||||||||||||||||
| STRING | P01106. | ||||||||||||||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||||||||||||||
| GlycoSuiteDB | P01106. | ||||||||||||||||||||||||||||||||||||
| PhosphoSite | P01106. | ||||||||||||||||||||||||||||||||||||
2-D gel databases | |||||||||||||||||||||||||||||||||||||
| SWISS-2DPAGE | P01106. | ||||||||||||||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||||||||||||||
| PRIDE | P01106. | ||||||||||||||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||||||||||||||
| Ensembl | ENST00000377970; ENSP00000367207; ENSG00000136997; Homo sapiens. [Genome view] | ||||||||||||||||||||||||||||||||||||
| GeneID | 4609. | ||||||||||||||||||||||||||||||||||||
| KEGG | hsa:4609. | ||||||||||||||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||||||||||||||
| CTD | 4609. | ||||||||||||||||||||||||||||||||||||
| GeneCards | GC08P128817. | ||||||||||||||||||||||||||||||||||||
| H-InvDB | HIX0007784. | ||||||||||||||||||||||||||||||||||||
| HGNC | HGNC:7553. MYC. | ||||||||||||||||||||||||||||||||||||
| MIM | 190080. gene. | ||||||||||||||||||||||||||||||||||||
| Orphanet | 543. Burkitt lymphoma. | ||||||||||||||||||||||||||||||||||||
| PharmGKB | PA31353. | ||||||||||||||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||||||||||||||
| eggNOG | prNOG11147. | ||||||||||||||||||||||||||||||||||||
| HOGENOM | HBG445611. | ||||||||||||||||||||||||||||||||||||
| HOVERGEN | P01106. | ||||||||||||||||||||||||||||||||||||
| InParanoid | P01106. | ||||||||||||||||||||||||||||||||||||
| PhylomeDB | P01106. | ||||||||||||||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||||||||||||||
| Pathway_Interaction_DB | wnt_canonical_pathway. Canonical Wnt signaling pathway. ceramidepathway. Ceramide signaling pathway. foxm1pathway. FOXM1 transcription factor network. il2_pi3kpathway. IL2 signaling events mediated by PI3K. il2_stat5pathway. IL2 signaling events mediated by STAT5. il2_1pathway. IL2-mediated signaling events. il6_7pathway. IL6-mediated signaling events. pdgfrbpathway. PDGFR-beta signaling pathway. ps1pathway. Presenilin action in Notch and Wnt signaling. smad2_3nuclearpathway. Regulation of nuclear SMAD2/3 signaling. telomerasepathway. Regulation of Telomerase. | ||||||||||||||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||||||||||||||
| ArrayExpress | P01106. | ||||||||||||||||||||||||||||||||||||
| Bgee | P01106. | ||||||||||||||||||||||||||||||||||||
| CleanEx | HS_MYC. | ||||||||||||||||||||||||||||||||||||
| Genevestigator | P01106. | ||||||||||||||||||||||||||||||||||||
| GermOnline | ENSG00000136997. Homo sapiens. | ||||||||||||||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||||||||||||||
| InterPro | IPR001092. HLH_DNA-bd_dom. IPR011598. HLH_DNA_bd. IPR003327. Myc-LZ. IPR002418. Tscrpt_reg_Myc. IPR012682. Tscrpt_reg_Myc_N. [Graphical view] | ||||||||||||||||||||||||||||||||||||
| Gene3D | G3DSA:4.10.280.10. HLH_DNA_bd. 1 hit. | ||||||||||||||||||||||||||||||||||||
| Pfam | PF00010. HLH. 1 hit. PF02344. Myc-LZ. 1 hit. PF01056. Myc_N. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||||||||
| PRINTS | PR00044. LEUZIPPRMYC. | ||||||||||||||||||||||||||||||||||||
| SMART | SM00353. HLH. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||||||||
| PROSITE | PS50888. HLH. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||||||||||||||
Other Resources | |||||||||||||||||||||||||||||||||||||
| NextBio | 17740. | ||||||||||||||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||||||||||||||
Entry information
| Entry name | MYC_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P01106 Secondary accession number(s): A8WFE7, P01107, Q14026 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 8 Human chromosome 8: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with


